Cargando…
Effects of PKM2 on global metabolic changes and prognosis in hepatocellular carcinoma: from gene expression to drug discovery
BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant tumor that threatens global human health. High PKM2 expression is widely reported in multiple cancers, especially in HCC. This study aimed to explore the effects of PKM2 on global gene expression, metabolic damages, patient prognosis, and mul...
Autores principales: | Lv, Wen-Wen, Liu, Dahai, Liu, Xing-Cun, Feng, Tie-Nan, Li, Lei, Qian, Bi-Yun, Li, Wen-Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249977/ https://www.ncbi.nlm.nih.gov/pubmed/30463528 http://dx.doi.org/10.1186/s12885-018-5023-0 |
Ejemplares similares
-
High PKM2 expression is independently correlated with decreased overall survival in hepatocellular carcinoma
por: Lu, Dong-Hui, et al.
Publicado: (2018) -
Non-metabolic enzyme function of PKM2 in hepatocellular carcinoma: A review
por: Zhang, Shuangxia, et al.
Publicado: (2023) -
PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014) -
Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma
por: Dayton, Talya L., et al.
Publicado: (2016) -
PKM2 promotes reductive glutamine metabolism
por: Liu, Miao, et al.
Publicado: (2018)